AI assistant
Sending…
Sopharma AD — Regulatory Filings 2021
Dec 6, 2021
2543_rns_2021-12-06_b76c87d2-4cd8-4fce-afd8-e4e48660b951.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Current report №160/ 2021 Dated December 6, 2021
NOTIFICATION
"Sopharma" AD (the Company) notifies that for November 2021 the Company recorded a decrease in sales of 9% compared to the same month of the previous year, incl. 42% increase in domestic sales and 25% decrease in export sales.
For the eleven months of 2021 the revenues from sales of products decrease by 3% compared to the same period of 2020, incl. 21% increase of sales for the domestic market and 15% decrease in export sales.
Ognian Donev
More from Sopharma AD
Director's Dealing
2026
Jun 5
Director's Dealing
2026
Jun 5
Director's Dealing
2026
Jun 5
Director's Dealing
2026
Jun 5
Transaction in Own Shares
2026
Jun 5
Director's Dealing
2026
Jun 4
Transaction in Own Shares
2026
Jun 4
Director's Dealing
2026
Jun 3
Transaction in Own Shares
2026
Jun 3
Director's Dealing
2026
Jun 2